Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0848120110360040173
International Journal of Oral Biology
2011 Volume.36 No. 4 p.173 ~ p.178
TNF¥á Increases the Expression of ¥â2 Adrenergic Receptors in Osteoblasts
Baek Jeong-Hwa

Baek Kyung-Hwa
Lee Hye-Lim
Hwang Hyo-Rin
Park Hyun-Jung
Kwon A-Rang
Abdul S. Qadir
Abstract
Tumor necrosis factor alpha (TNF¥á) is a multifunctional cytokine that is elevated in inflammatory diseases such as atherosclerosis, diabetes and rheumatoid arthritis. Recent evidence has suggested that ¥â2 adrenergic receptor(¥â2AR) activation in osteoblasts suppresses osteogenic activity. In the present study, we explored whether TNF¥á modulates ¥âAR expression in osteoblastic cells and whether this regulation is associated with the inhibition of osteoblast differentiation by TNF¥á. In the experiments, we used C2C12 cells, MC3T3- E1 cells and primary cultured mouse bone marrow stromal cells. Among the three subtypes of ¥âAR, ¥â2 and ¥â3AR were found in our analysis to be upregulated by TNF¥á. Moreover, isoproterenol-induced cAMP production was observed to be significantly enhanced in TNF¥á-primed C2C12 cells, indicating that TNF¥á enhances ¥â2AR signaling in osteoblasts.TNF¥á was further found in C2C12 cells to suppress bone morphogenetic protein 2-induced alkaline phosphatase(ALP) activity and the expression of osteogenic marker genes including Runx2, ALP and osteocalcin. Propranolol, a¥â2AR antagonist, attenuated this TNF¥á suppression of osteogenic differentiation. TNF¥á increased the expression ofreceptor activator of NF-¥êB ligand (RANKL), an essential osteoclastogenic factor, in C2C12 cells which was againblocked by propranolol. In summary, our data show that TNF¥á increases ¥â2AR expression in osteoblasts and that ablockade of ¥â2AR attenuates the suppression of osteogenic differentiation and stimulation of RANKL expression byTNF¥á. These findings imply that a crosstalk between TNF¥á
KEYWORD
TNF¥á, ¥â2 adrenergic receptor, osteoblasts
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed